In conclusion, this is the first clinical trial evidence that supplementation with prebiotic inulin following brief metronidazole therapy can further reduce ALT after four weeks of VLCD therapy in patients with NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.